The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome per 2017 WHO guideline compared to de novo MDS.
 
Omar Alkharabsheh
No Relationships to Disclose
 
Aref Al-Kali
Research Funding - Ambit BioSciences (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); H3 Biomedicine (Inst); MedImmune (Inst); Novartis (Inst); Onconova Therapeutics (Inst)
 
Salwa Shihadeh Saadeh
No Relationships to Disclose
 
Rong He
No Relationships to Disclose
 
David Viswanatha
No Relationships to Disclose
 
Patricia T. Greipp
No Relationships to Disclose
 
Kaaren Reichard
No Relationships to Disclose
 
Mithun Vinod Shah
No Relationships to Disclose
 
Naseema Gangat
No Relationships to Disclose
 
Mrinal Mahesh Patnaik
No Relationships to Disclose
 
William J. Hogan
No Relationships to Disclose
 
Mark Robert Litzow
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Actinium Pharmaceuticals; Amgen; Astellas Pharma
Travel, Accommodations, Expenses - Amgen
 
Hassan Alkhateeb
No Relationships to Disclose
 
Phuong L. Nguyen
No Relationships to Disclose